Cross-priming is under control of the relB gene

Scandinavian Journal of Immunology

Volumn 56, Issue 3, 2002, Pages 219-223

  Castiglioni, P ^a   Janssen, E M ^a,b   Prilliman, K R ^a,b   Gerloni, M ^a   Schoenberger, S ^a,b   Zanetti, M ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; TRANSCRIPTION FACTOR RELB; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL TRANSFER; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; EMBRYO; GENE CONTROL; GENE PROBE; HUMAN ADENOVIRUS 5; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIMED LYMPHOCYTE TYPING; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CYTOTOXICITY TESTS, IMMUNOLOGIC; LANGERHANS CELLS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSPLANTATION CHIMERA;

EID: 0036040132     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01144.x     Document Type: Article

References (25)

1. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not crossreact in the cytotoxic assay
2. + T cell help
3. In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter
4. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
5. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: Antigen presentation by non-muscle cells
6. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
7. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens
8. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo
9. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo
10. + dendritic cells
11. Expression of relB transcripts during lymphoid organ development: Specific expression in dendritic antigen-presenting cells
12. A recessive defect in lymphocyte or granulocyte function caused by an integrated transgene
13. Expression of relB is required for the development of thymic medulla and dendritic cells
14. DNA immunization in relB-deficient mice discloses a role for dendritic cells in IgM→IgG1 switch in vivo
15. Cross-priming of CTL responses in vivo does not require antigenic peptides in the endoplasmic reticulum of immunizing cells
16. The JAM test. A simple assay for DNA fragmentation and cell death
17. Somatic transgene immunization with DNA encoding an immunoglobulin heavy chain
18. Engineering vaccines with heterologous B and T cell epitopes using immunoglobulin genes
19. Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes
20. + dendritic cells
21. Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation
22. + dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node
23. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family
24. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines
25. CD8a(+) dendritic cells originate from the CD8a(-) dendritic cell subset by a maturation process involving CD8 a, DEC-205, and CD24 up-regulation